2020;Tursich et al. 2014; von Känel et al. 2007), with an anomalous increase in the anti‐inflammatory cytokine IL‐10 levels specifically in female patients (Malik et al. 2022; Renner et al. 2022; Toft et al. 2022). In addition, Mendelian randomization analysis revealed that genetically predicted elevated IL‐17 levels might be associated with a lower risk of PTSD (Zuo et al. 2023). The gene discussed is IL10; the disease is post-traumatic stress disorder.